Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Sea sponge could be key in fight against TB

Sea sponge could be key in fight against TB

Date time 7 October, 2019
News Type News type Media release
An Australian sea sponge could hold the key to successfully combatting the deadly disease tuberculosis (TB), a new study from the Centenary Institute and the University of Sydney suggests.

Reported in the journal ‘Nature Scientific Reports’, the sea sponge was found to contain an exceptionally potent anti-bacterial agent able to inhibit Mycobacterium tuberculosis–the bacteria that causes TB in humans.

Every year more than 10 million people fall ill with TB and 1.8 million die from the disease. The new finding has the potential to open-up a new avenue of research to target what is the world’s top infectious disease killer.

“TB is a major global health problem and our battle against this resilient and deadly disease is incredibly difficult,” said the study’s lead author, Dr Diana Quan, a researcher affiliated with the Centenary Institute and the Microbial Pathogenesis and Immunity Group led by Professor Jamie Triccas at the University of Sydney.

“Effective antibiotics for TB are difficult to develop, there are constant issues with new drug-resistant TB strains and our current treatment approach for TB is both lengthy and complicated,” she said. “There is an urgent need for new drugs and antibiotics which can shorten and simplify TB treatment in order to combat this burgeoning TB pandemic.”

In the reported study, a sea sponge from the Tedaniidae family was examined by Dr Quan and found to yield compounds that displayed strong inhibitory potency against TB and also importantly, against drug-resistant strains of the disease. Following analysis, the active component from the sponge was identified as bengamide B which was also found to be non-toxic when tested against human cell lines.

“This is an extremely exciting finding,” said Dr Quan. “Bengamide B shows significant potential as a new class of compound for the treatment of tuberculosis and also importantly, for the treatment of drug-resistant TB which is an ever increasing obstacle to TB eradication around the world.”

The sea sponge was harvested off the Queensland coast and was one of approximately 1,500 different marine samples tested by Dr Quan for possible effectiveness against TB over the course of a three year program.

Read the full media release here.

ABC news interview with Dr Quan

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • Blood test discovery could help identify head and neck cancer patients at higher risk of relapse

    Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.
    News Type: Media release
    Date 25 Feb 2026
  • New FAP-Index could transform early detection of severe liver disease

    Researchers from the Centenary Institute have developed a new diagnostic tool, the FAP-Index, that could significantly improve how doctors identify people at risk of serious liver damage caused by metabolic fatty liver disease. The condition affects around one in three Australians with cases projected to increase by 25% to over 7 million by 2030.
    News Type: Media release
    Date 20 Feb 2026
  • First‑of‑its‑kind AI platform to improve cancer treatment decisions

    Centenary researchers have been awarded funding to commercialise a first‑of‑its‑kind medical AI platform designed to improve treatment decisions and reduce unnecessary surgeries for Australian cancer patients. The project, funded through the Australian Government’s Australia’s Economic Accelerator (AEA) Ignite program and led by Dr Yagiz Aksoy, Senior Clinical Research Fellow at Centenary’s Centre for Biomedical AI, ...
    News Type: Research News
    Date 19 Feb 2026
  • New initiative to allow researchers to decode disease like never before

    The Centenary Institute and the University of Sydney have launched a major new initiative that brings next-generation spatial biology technologies together to transform how health threats such as cancer, cardiovascular diseases and infectious diseases are studied and understood.
    News Type: Research News
    Date 11 Feb 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram